AMY JONES: Open Payments
NPI 1962956623 · OXFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 30 payments from 7 companies in 2025. Trend: 2023 $963 · 2024 $705 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $313 |
| GlaxoSmithKline, LLC. | 4 | $58 |
| Novo Nordisk Inc | 2 | $47 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| PFIZER INC. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, QULIPTA, Wegovy, SHINGRIX, GARDASIL 9, ELIQUIS, GEMTESA.
Industry payments across CT — which companies pay providers there.
